GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Aug 25, 2025, 4:00 PM
1.082
-0.008 (-0.74%)
After-hours: Aug 25, 2025, 6:40 PM EDT

GT Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
4711299336
Upgrade
Market Cap Growth
84.65%-35.48%-63.37%-69.01%159.67%556.05%
Upgrade
Enterprise Value
-10-585758
Upgrade
Last Close Price
1.093.057.6526.5791.50216.24
Upgrade
PB Ratio
1.25-4.081.412.464.25-1.22
Upgrade
P/TBV Ratio
1.36-1.412.464.25-
Upgrade
Debt / Equity Ratio
--0.010.020.00-0.89
Upgrade
Quick Ratio
2.270.672.113.343.120.15
Upgrade
Current Ratio
3.090.722.123.353.140.16
Upgrade
Return on Equity (ROE)
-181.98%-453.39%-79.09%-124.15%--
Upgrade
Return on Assets (ROA)
-82.45%-97.89%-55.02%-54.33%-190.04%-139.59%
Upgrade
Return on Capital (ROIC)
-130.90%-306.19%-87.28%-78.50%-381.56%-
Upgrade
Earnings Yield
-244.48%-193.14%-71.93%-72.42%-62.35%-78.97%
Upgrade
FCF Yield
-268.74%-189.36%-83.81%-52.77%-16.77%-20.27%
Upgrade
Buyback Yield / Dilution
-64.62%-40.78%-26.87%-13.18%-542.06%-29.59%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q